agilon health inc header image

agilon health inc

AGL

Equity

ISIN null / Valor 110653729

New York Stock Exchange, Inc (2026-02-20)
USD 0.44+8.24%

agilon health inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Agilon Health Inc. operates as a healthcare company that focuses on transforming the primary care model for senior patients through its Medicare-centric Total Care Model. This innovative approach leverages a unified operating platform that integrates people, processes, and technology to assist physician partners in identifying care gaps, enhancing practice growth, and improving patient outcomes. Unlike companies that aim to own or directly manage physician practices, Agilon positions itself as a collaborative partner, investing 100% of the capital in joint ventures with independent primary-care and multispecialty practices. These partnerships are designed to maintain the autonomy of physicians while enabling them to manage global risk more effectively. Agilon's model emphasizes the importance of the physician-patient relationship and supports the long-term financial sustainability of practices. The company has established strategic relationships with leading national and regional health plans, facilitating a focus on delivering consistent, high-quality care and managing overall health costs efficiently. Through its approach, Agilon aims to empower physicians to deliver superior care to their communities while navigating the complexities of the healthcare system.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-87.9%1Y
-98.1%3Y
%5Y

Performance

116%1Y
95.1%3Y
83.7%5Y

Volatility

Market cap

181 M

Market cap (USD)

Daily traded volume (Shares)

5,888,589

Daily traded volume (Shares)

1 day high/low

1.96 / 1.835

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

MedCap AB
MedCap AB MedCap AB Valor: 34063678
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.05%SEK 483.00
Cardinal Health Inc
Cardinal Health Inc Cardinal Health Inc Valor: 196652
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.75%USD 224.44
aap Implantate AG
aap Implantate AG aap Implantate AG Valor: 57872565
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 1.45
Ambea AB
Ambea AB Ambea AB Valor: 36138415
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%SEK 124.50
Vimian Group AB
Vimian Group AB Vimian Group AB Valor: 111662981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%SEK 26.66
Inari Medical Inc
Inari Medical Inc Inari Medical Inc Valor: 52764794
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 79.97
Alcon Inc.
Alcon Inc. Alcon Inc. Valor: 43249246
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.56%CHF 64.28
BACHEM HOLDING LTD
BACHEM HOLDING LTD BACHEM HOLDING LTD Valor: 117649372
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.59%CHF 65.05
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A. Valor: 2791431
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.62%CHF 19.26
EssilorLuxottica SA
EssilorLuxottica SA EssilorLuxottica SA Valor: 497537
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.23%EUR 238.20